Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy

Published:2017-03 Issue: Volume:231 Page:115-119
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Maurizi Niccoló,Tanini Ilaria^ORCID,Olivotto Iacopo,Amendola Ernesto,Limongelli Giuseppe,Losi Maria Angela,Allocca Giuseppe,Perego Giovanni Battista^ORCID,Pieragnoli Paolo,Ricciardi Giuseppe,De Filippo Paolo^ORCID,Ferrari Paola,Quarta Giovanni,Viani Stefano^ORCID,Rapacciuolo Antonio^ORCID,Bongiorni Maria Grazia,Cecchi Franco^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur. Heart J.,2014

2. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines;Gersh;Circulation,2011

3. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine;Maron;J. Am. Coll. Cardiol.,2014

4. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy;Maron;J. Am. Coll. Cardiol.,2013

5. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead;Morrison;J. Cardiovasc. Electrophysiol.,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy;International Journal of Cardiology;2024-08

2. Validation of the PRAETORIAN score in a large subcutaneous implantable cardioverter-defibrillator collective: Usefulness in clinical routine;Heart Rhythm;2024-07

3. Efficacy and safety of the subcutaneous implantable cardioverter-defibrillator in patients with and without obesity: A meta-analysis;Heart Rhythm;2024-07

4. ICD for Sudden Cardiac Death Prevention and New Pharmaceutical Treatment Options in Hypertrophic Obstructive Cardiomyopathy;Updates on Cardiac Defibrillation, Cardioversion and AED Development;2024-01-31

5. Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease;Cardiac Electrophysiology Clinics;2023-12